{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:11:04Z","timestamp":1790745064549,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2016-2620"],"award-info":[{"award-number":["PICT 2016-2620"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2018-03688"],"award-info":[{"award-number":["PICT 2018-03688"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2011-2783"],"award-info":[{"award-number":["PICT 2011-2783"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["id18467"],"award-info":[{"award-number":["id18467"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB-1817582"],"award-info":[{"award-number":["MCB-1817582"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA117907"],"award-info":[{"award-number":["R01CA117907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM120109"],"award-info":[{"award-number":["R01GM120109"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor cell dissemination in cancer patients is associated with a significant reduction in their survival and quality of life. The ubiquitination pathway plays a fundamental role in the maintenance of protein homeostasis both in normal and stressed conditions and its dysregulation has been associated with malignant transformation and invasive potential of tumor cells, thus highlighting its value as a potential therapeutic target. In order to identify novel molecular targets of tumor cell migration and invasion we performed a genetic screen with an shRNA library against ubiquitination pathway-related genes. To this end, we set up a protocol to specifically enrich positive migration regulator candidates. We identified the deubiquitinase USP19 and demonstrated that its silencing reduces the migratory and invasive potential of highly invasive breast cancer cell lines. We extended our investigation in vivo and confirmed that mice injected with USP19 depleted cells display increased tumor-free survival, as well as a delay in the onset of the tumor formation and a significant reduction in the appearance of metastatic foci, indicating that tumor cell invasion and dissemination is impaired. In contrast, overexpression of USP19 increased cell invasiveness both in vitro and in vivo, further validating our findings. More importantly, we demonstrated that USP19 catalytic activity is important for the control of tumor cell migration and invasion, and that its molecular mechanism of action involves LRP6, a Wnt co-receptor. Finally, we showed that USP19 overexpression is a surrogate prognostic marker of distant relapse in patients with early breast cancer. Altogether, these findings demonstrate that USP19 might represent a novel therapeutic target in breast cancer.<\/jats:p>","DOI":"10.1038\/s41389-021-00318-x","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:02:49Z","timestamp":1615593769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-4893","authenticated-orcid":false,"given":"Fabiana Alejandra","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Hayde\u00e9","family":"Enrique\u0301 Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-515X","authenticated-orcid":false,"given":"Ezequiel Hern\u00e1n","family":"Calvo Roitberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molishree Umesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahwan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-2369","authenticated-orcid":false,"given":"Martin Carlos","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Dufrusine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Buglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Laurenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-915X","authenticated-orcid":false,"given":"Gianluca","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-4476","authenticated-orcid":false,"given":"Rossano","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn Maximiliano","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6349-8895","authenticated-orcid":false,"given":"Mario","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"318_CR1","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/cphy.c110012","volume":"2","author":"X Trepat","year":"2012","unstructured":"Trepat, X., Chen, Z. & Jacobson, K. Cell migration. Compr. Physiol. 2, 2369\u20132392 (2012).","journal-title":"Compr. Physiol."},{"key":"318_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-207-6_1","volume":"769","author":"M Vicente-Manzanares","year":"2011","unstructured":"Vicente-Manzanares, M. & Horwitz, A. R. Cell migration: an overview. Methods Mol. Biol. 769, 1\u201324 (2011).","journal-title":"Methods Mol. Biol."},{"key":"318_CR3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Investig. 119, 1438\u20131449 (2009).","journal-title":"J. Clin. Investig."},{"key":"318_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang, J. & Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818\u2013829 (2008).","journal-title":"Dev. Cell"},{"key":"318_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006).","journal-title":"Cell"},{"key":"318_CR6","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1200\/JCO.2005.03.089","volume":"23","author":"F Lefranc","year":"2005","unstructured":"Lefranc, F., Brotchi, J. & Kiss, R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 23, 2411\u20132422 (2005).","journal-title":"J. Clin. Oncol."},{"key":"318_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1593\/neo.07130","volume":"9","author":"V Megalizzi","year":"2007","unstructured":"Megalizzi, V. et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia 9, 358\u2013369 (2007).","journal-title":"Neoplasia"},{"key":"318_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tips.2013.03.001","volume":"34","author":"A Wells","year":"2013","unstructured":"Wells, A., Grahovac, J., Wheeler, S., Ma, B. & Lauffenburger, D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharm. Sci. 34, 283\u2013289 (2013).","journal-title":"Trends Pharm. Sci."},{"key":"318_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.addr.2011.04.008","volume":"63","author":"T Palmer","year":"2012","unstructured":"Palmer, T., Ashby, W., Lewis, J. & Zijlstra, A. Targeting tumor cell motility to prevent metastasis. Adv. Drug Deliv. Rev. 63, 568\u2013581 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"318_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrd2372","volume":"11","author":"BL Eckhardt","year":"2012","unstructured":"Eckhardt, B. L., Francis, P. A., Parker, B. S. & Anderson, R. L. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat. Rev. Drug Discov. 11, 479\u2013497 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"318_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0006-291X(78)91249-4","volume":"81","author":"A Ciechanover","year":"1978","unstructured":"Ciechanover, A., Hod, Y. & Hershko, A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. Commun. 81, 1100\u20131105 (1978).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"318_CR12","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1073\/pnas.77.4.1783","volume":"77","author":"A Hershko","year":"1980","unstructured":"Hershko, A., Ciechanover, A., Heller, H., Haas, A. & Rose, I. A. Proposed role of ATP in protein breakdown: conjugation of proteins with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc. Natl Acad. Sci. USA 77, 1783\u20131786 (1980).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"318_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-051810-094654","volume":"81","author":"K Husnjak","year":"2012","unstructured":"Husnjak, K. & Dikic, I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291\u2013322 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"318_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/BJ20111815","volume":"442","author":"A Schaefer","year":"2012","unstructured":"Schaefer, A., Nethe, M. & Hordijk, P. L. Ubiquitin links to cytoskeletal dynamics, cell adhesion and migration. Biochem. J. 442, 13\u201325 (2012).","journal-title":"Biochem. J."},{"key":"318_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SMB Nijman","year":"2005","unstructured":"Nijman, S. M. B. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773\u2013786 (2005).","journal-title":"Cell"},{"key":"318_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.18632\/oncotarget.12284","volume":"8","author":"H Yao","year":"2017","unstructured":"Yao, H. et al. Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8, 1913\u20131924 (2017).","journal-title":"Oncotarget"},{"key":"318_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147515","volume":"11","author":"WT He","year":"2016","unstructured":"He, W. T. et al. Cytoplasmic ubiquitin-specific protease 19 (USP19) modulates aggregation of polyglutamine-expanded ataxin-3 and Huntingtin through the HSP90 chaperone. PLoS ONE 11, e0147515 (2016).","journal-title":"PLoS ONE"},{"key":"318_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1091\/mbc.E14-06-1129","volume":"26","author":"B Wiles","year":"2015","unstructured":"Wiles, B. et al. USP19 deubiquitinating enzyme inhibits muscle cell differentiation by suppressing unfolded-protein response signaling. Mol. Biol. Cell 26, 913\u2013923 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"318_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/embor.2009.69","volume":"10","author":"GC Hassink","year":"2009","unstructured":"Hassink, G. C. et al. The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Rep. 10, 755\u2013761 (2009).","journal-title":"EMBO Rep."},{"key":"318_CR20","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1074\/jbc.M113.538934","volume":"289","author":"JG Lee","year":"2014","unstructured":"Lee, J. G., Kim, W., Gygi, S. & Ye, Y. Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation. The. J. Biol. Chem. 289, 3510\u20133517 (2014).","journal-title":"J. Biol. Chem."},{"key":"318_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13711-7","volume":"7","author":"WT He","year":"2017","unstructured":"He, W. T. et al. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19. Sci. Rep. 7, 14797 (2017).","journal-title":"Sci. Rep."},{"key":"318_CR22","doi-asserted-by":"publisher","first-page":"e19083","DOI":"10.7554\/eLife.19083","volume":"5","author":"E Perrody","year":"2016","unstructured":"Perrody, E. et al. Ubiquitin-dependent folding of the Wnt signaling coreceptor LRP6. eLife 5, e19083 (2016).","journal-title":"eLife"},{"key":"318_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-280","volume":"11","author":"B Bilir","year":"2013","unstructured":"Bilir, B., Kucuk, O. & Moreno, C. S. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J. Transl. Med. 11, 12 (2013).","journal-title":"J. Transl. Med."},{"key":"318_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/modpathol.2010.205","volume":"24","author":"FC Geyer","year":"2011","unstructured":"Geyer, F. C. et al. beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Modern Pathol. 24, 209\u2013231 (2011).","journal-title":"Modern Pathol."},{"key":"318_CR25","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2353\/ajpath.2010.091125","volume":"176","author":"AI Khramtsov","year":"2010","unstructured":"Khramtsov, A. I. et al. Wnt\/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 176, 2911\u20132920 (2010).","journal-title":"Am. J. Pathol."},{"key":"318_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2317","volume":"11","author":"Y Matsuda","year":"2009","unstructured":"Matsuda, Y., Schlange, T., Oakeley, E. J., Boulay, A. & Hynes, N. E. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res. 11, R32 (2009).","journal-title":"Breast Cancer Res."},{"key":"318_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11081162","volume":"11","author":"J Raisch","year":"2019","unstructured":"Raisch, J., Cote-Biron, A. & Rivard, N. A role for the WNT co-receptor LRP6 in pathogenesis and therapy of epithelial cancers. Cancers 11, 1\u201323 (2019).","journal-title":"Cancers"},{"key":"318_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2144\/000113353","volume":"48","author":"H Wiggins","year":"2010","unstructured":"Wiggins, H. & Rappoport, J. An agarose spot assay for chemotactic invasion. Biotechniques 48, 121\u2013124 (2010).","journal-title":"Biotechniques"},{"key":"318_CR29","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1101\/gad.237743.114","volume":"28","author":"L Salvany","year":"2014","unstructured":"Salvany, L., Muller, J., Guccione, E. & Rorth, P. The core and conserved role of MAL is homeostatic regulation of actin levels. Genes Dev. 28, 1048\u20131053 (2014).","journal-title":"Genes Dev."},{"key":"318_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00949-4","volume":"7","author":"M Ahmed","year":"2017","unstructured":"Ahmed, M. et al. Agarose spot as a comparative method for in situ analysis of simultaneous chemotactic responses to multiple chemokines. Sci. Rep. 7, 1075 (2017).","journal-title":"Sci. Rep."},{"key":"318_CR31","doi-asserted-by":"publisher","unstructured":"Rameshwar, P., Patel, S., Pine, S. & Rameshwar, P. Noble agar assay for self-renewal. Protoc. Exchange 1\u20135, https:\/\/doi.org\/10.1038\/protex.2013.021 (2013).","DOI":"10.1038\/protex.2013.021"},{"key":"318_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-429","volume":"13","author":"M Ampuja","year":"2013","unstructured":"Ampuja, M. et al. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 13, 1\u201313 (2013).","journal-title":"BMC Cancer"},{"key":"318_CR33","doi-asserted-by":"publisher","first-page":"11811","DOI":"10.1073\/pnas.1006737107","volume":"107","author":"EF Farias","year":"2010","unstructured":"Farias, E. F. et al. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. Proc. Natl Acad. Sci. USA 107, 11811\u201311816 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"318_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32507-x","volume":"8","author":"AM Ibrahim","year":"2018","unstructured":"Ibrahim, A. M. et al. Fibulin-2 is required for basement membrane integrity of mammary epithelium. Sci. Rep. 8, 14139 (2018).","journal-title":"Sci. Rep."},{"key":"318_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/1541-7786.MCR-08-0574","volume":"7","author":"R Sadej","year":"2009","unstructured":"Sadej, R. et al. CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol. Cancer Res. 7, 787\u2013798 (2009).","journal-title":"Mol. Cancer Res."},{"key":"318_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fonc.2019.01323","volume":"9","author":"MC Llorens","year":"2019","unstructured":"Llorens, M. C. et al. PKCalpha modulates epithelial-to-mesenchymal transition and invasiveness of breast cancer cells through ZEB1. Front. Oncol. 9, 1323 (2019).","journal-title":"Front. Oncol."},{"key":"318_CR37","doi-asserted-by":"publisher","first-page":"i237","DOI":"10.1093\/bioinformatics\/btq182","volume":"26","author":"CJ Vaske","year":"2010","unstructured":"Vaske, C. J. et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26, i237\u2013i245 (2010).","journal-title":"Bioinformatics"},{"key":"318_CR38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ijc.27751","volume":"132","author":"R Lattanzio","year":"2013","unstructured":"Lattanzio, R. et al. Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy. Int. J. Cancer 132, 1022\u20131031 (2013).","journal-title":"Int. J. Cancer"},{"key":"318_CR39","doi-asserted-by":"publisher","first-page":"C863","DOI":"10.1152\/ajpcell.00272.2018","volume":"315","author":"Q Chen","year":"2018","unstructured":"Chen, Q. et al. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1\/MEK\/ERK pathway. Am. J. Physiol. Cell Physiol. 315, C863\u2013C872 (2018).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"318_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2018.05.156","volume":"502","author":"AT Ouchida","year":"2018","unstructured":"Ouchida, A. T. et al. USP10 regulates the stability of the EMT-transcription factor Slug\/SNAI2. Biochem. Biophys. Res. Commun. 502, 429\u2013434 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"318_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/1878-0261.12596","volume":"14","author":"T Yuan","year":"2020","unstructured":"Yuan, T. et al. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein. Mol. Oncol. 14, 197\u2013210 (2020).","journal-title":"Mol. Oncol."},{"key":"318_CR42","doi-asserted-by":"crossref","unstructured":"Hanahan, D. & Weinberg, R. A. in Holland-Frei Cancer Medicine 9th edn. 1 (eds Bast R. C. Jr., et al.) (Wiley Blackwell, 2017).","DOI":"10.1002\/9781119000822.hfcm002"},{"key":"318_CR43","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","volume":"79","author":"DR Welch","year":"2019","unstructured":"Welch, D. R. & Hurst, D. R. Defining the hallmarks of metastasis. Cancer Res 79, 3011\u20133027 (2019).","journal-title":"Cancer Res"},{"key":"318_CR44","doi-asserted-by":"publisher","first-page":"E693","DOI":"10.1152\/ajpendo.00281.2004","volume":"288","author":"L Combaret","year":"2005","unstructured":"Combaret, L. et al. USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states. Am. J. Physiol. Endocrinol. Metab. 288, E693\u2013E700 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"318_CR45","doi-asserted-by":"publisher","first-page":"866","DOI":"10.15252\/embj.201593596","volume":"35","author":"S Jin","year":"2016","unstructured":"Jin, S. et al. USP19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin-1. EMBO J. 35, 866\u2013880 (2016).","journal-title":"EMBO J."},{"key":"318_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37264-5","volume":"9","author":"ME Gierisch","year":"2019","unstructured":"Gierisch, M. E. et al. USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth. Sci. Rep. 9, 951 (2019).","journal-title":"Sci. Rep."},{"key":"318_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1128\/MCB.00329-08","volume":"29","author":"Y Lu","year":"2009","unstructured":"Lu, Y. et al. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1. Mol. Cell Biol. 29, 547\u2013558 (2009).","journal-title":"Mol. Cell Biol."},{"key":"318_CR48","doi-asserted-by":"publisher","first-page":"34759","DOI":"10.18632\/oncotarget.8976","volume":"7","author":"K Lim","year":"2016","unstructured":"Lim, K. et al. Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A. Oncotarget 7, 34759\u201334772 (2016).","journal-title":"Oncotarget"},{"key":"318_CR49","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi, H. & Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica et. biophysica acta 1773, 642\u2013652 (2007).","journal-title":"Biochimica et. biophysica acta"},{"key":"318_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI71602","volume":"124","author":"NM Weathington","year":"2014","unstructured":"Weathington, N. M. & Mallampalli, R. K. Emerging therapies targeting the ubiquitin proteasome system in cancer. J. Clin. Investig. 124, 6\u201312 (2014).","journal-title":"J. Clin. Investig."},{"key":"318_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2019.03.003","volume":"199","author":"G Veggiani","year":"2019","unstructured":"Veggiani, G., Gerpe, M. C. R., Sidhu, S. S. & Zhang, W. Emerging drug development technologies targeting ubiquitination for cancer therapeutics. Pharm. Ther. 199, 139\u2013154 (2019).","journal-title":"Pharm. Ther."},{"key":"318_CR52","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.4155\/fmc.15.148","volume":"7","author":"JK Morrow","year":"2015","unstructured":"Morrow, J. K., Lin, H.-K., Sun, S.-C. & Zhang, S. Targeting ubiquitination for cancer therapies. Future Medicinal Chem. 7, 2333\u20132350 (2015).","journal-title":"Future Medicinal Chem."},{"key":"318_CR53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/cr.2016.31","volume":"26","author":"X Huang","year":"2016","unstructured":"Huang, X. & Dixit, V. M. Drugging the undruggables: exploring the ubiquitin system for drug development. Cell Res. 26, 484\u2013498 (2016).","journal-title":"Cell Res."},{"key":"318_CR54","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1080\/15548627.2016.1173801","volume":"12","author":"J Cui","year":"2016","unstructured":"Cui, J., Jin, S. & Wang, R. F. The BECN1-USP19 axis plays a role in the crosstalk between autophagy and antiviral immune responses. Autophagy 12, 1210\u20131211 (2016).","journal-title":"Autophagy"},{"key":"318_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2217\/fmb-2017-0006","volume":"12","author":"Z Gu","year":"2017","unstructured":"Gu, Z., Shi, W., Zhang, L., Hu, Z. & Xu, C. USP19 suppresses cellular type I interferon signaling by targeting TRAF3 for deubiquitination. Future Microbiol 12, 767\u2013779 (2017).","journal-title":"Future Microbiol"},{"key":"318_CR56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.1900083","volume":"203","author":"CQ Lei","year":"2019","unstructured":"Lei, C. Q. et al. USP19 Inhibits TNF-alpha- and IL-1beta-Triggered NF-kappaB Activation by Deubiquitinating TAK1. J. Immunol. 203, 259\u2013268 (2019).","journal-title":"J. Immunol."},{"key":"318_CR57","doi-asserted-by":"publisher","first-page":"34759","DOI":"10.18632\/oncotarget.8976","volume":"7","author":"K-H Lim","year":"2016","unstructured":"Lim, K.-H. et al. Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A. Oncotarget 7, 34759\u201334772 (2016).","journal-title":"Oncotarget"},{"key":"318_CR58","doi-asserted-by":"publisher","first-page":"35380","DOI":"10.1074\/jbc.M111.282020","volume":"286","author":"Y Mei","year":"2011","unstructured":"Mei, Y., Hahn, A. A., Hu, S. & Yang, X. The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2. The. J. Biol. Chem. 286, 35380\u201335387 (2011).","journal-title":"J. Biol. Chem."},{"key":"318_CR59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.yexcr.2014.07.025","volume":"328","author":"N Nakamura","year":"2014","unstructured":"Nakamura, N., Harada, K., Kato, M. & Hirose, S. Ubiquitin-specific protease 19 regulates the stability of the E3 ubiquitin ligase MARCH6. Exp. Cell Res. 328, 207\u2013216 (2014).","journal-title":"Exp. Cell Res."},{"key":"318_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12145-1","volume":"10","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination. Nat. Commun. 10, 4115 (2019).","journal-title":"Nat. Commun."},{"key":"318_CR61","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1074\/jbc.M111.305615","volume":"287","author":"M Altun","year":"2012","unstructured":"Altun, M. et al. Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1alpha (HIF-1alpha) during hypoxia. J. Biol. Chem. 287, 1962\u20131969 (2012).","journal-title":"J. Biol. Chem."},{"key":"318_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17111829","volume":"17","author":"K Harada","year":"2016","unstructured":"Harada, K., Kato, M. & Nakamura, N. USP19-mediated deubiquitination facilitates the stabilization of HRD1 ubiquitin ligase. Int. J. Mol. Sci. 17, 1\u20139 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"318_CR63","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.18632\/oncotarget.11116","volume":"8","author":"M Wu","year":"2017","unstructured":"Wu, M. et al. USP19 deubiquitinates HDAC1\/2 to regulate DNA damage repair and control chromosomal stability. Oncotarget 8, 2197\u20132208 (2017).","journal-title":"Oncotarget"},{"key":"318_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015936","volume":"6","author":"Y Lu","year":"2011","unstructured":"Lu, Y., Bedard, N., Chevalier, S. & Wing, S. S. Identification of distinctive patterns of USP19-mediated growth regulation in normal and malignant cells. PLoS ONE 6, e15936 (2011).","journal-title":"PLoS ONE"},{"key":"318_CR65","doi-asserted-by":"publisher","first-page":"16445","DOI":"10.18632\/oncotarget.14860","volume":"8","author":"Z Li","year":"2017","unstructured":"Li, Z., Yin, S., Zhang, L., Liu, W. & Chen, B. Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis. Oncotarget 8, 16445\u201316455 (2017).","journal-title":"Oncotarget"},{"key":"318_CR66","first-page":"1659","volume":"16","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma. Oncol. Lett. 16, 1659\u20131665 (2018).","journal-title":"Oncol. Lett."},{"key":"318_CR67","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1073\/pnas.0911220107","volume":"107","author":"CC Liu","year":"2010","unstructured":"Liu, C. C., Prior, J., Piwnica-Worms, D. & Bu, G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc. Natl Acad. Sci. USA 107, 5136\u20135141 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"318_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcb.23350","volume":"113","author":"TD King","year":"2012","unstructured":"King, T. D., Suto, M. J. & Li, Y. The Wnt\/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J. Cell. Biochem. 113, 13\u201318 (2012).","journal-title":"J. Cell. Biochem."},{"key":"318_CR69","first-page":"1964","volume":"43","author":"W Hu","year":"2020","unstructured":"Hu, W. et al. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma. Oncol. Rep. 43, 1964\u20131974 (2020).","journal-title":"Oncol. Rep."},{"key":"318_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-7-S5-S7","volume":"7","author":"Q Liu","year":"2013","unstructured":"Liu, Q., Zhao, S., Su, P. & Yu, S. Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma. BMC Syst. Biol. 7, 1\u201311 (2013).","journal-title":"BMC Syst. Biol."}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00318-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T22:40:50Z","timestamp":1698014450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-021-00318-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1038\/s41389-021-00318-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.01.181883","asserted-by":"object"}]},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"28 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"28"}}